Alembic receives USFDA approval for Leflunomide drug

24 Nov 2011 Evaluate

Alembic has got an approval of US Food and Drug Administration (USFDA) for the generic version of arthritis drug Leflunomide. The approval is for 10 mg and 20 mg strengths of Leflunomide tablets.

Leflunomide is prescribed in active, moderate, and severe rheumatoid arthritis and psoriatic arthritis and is sold by French pharmaceutical major Sanofi-Aventis under the brand name Arava.

Alembic is a leading pharmaceutical company in India. The company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates.

Alembic Share Price

123.45 -1.75 (-1.40%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.